logo
Plus   Neg
Share
Email

Diploma Says FY Trading Remains In Line With Its View

Diploma Plc. (DPLM.L), in its trading update for the year ending 30 September 2019, said that trading has remained in line with its expectations with good underlying growth in Life Sciences and Controls and softer activity in the Industrial OEM Seals markets.

It expects revenues to grow by about 13%, comprising underlying revenue growth of5% and with 6% being contributed from acquisitions, net of disposals. Revenues are also likely to benefit from a 2% currency tailwind.

In Life Sciences, underlying revenues are expected to be up about 7%.

The company expects underlying revenues in Seals segment to be 1% ahead of last year.

In controls unit, underlying revenues are expected to be up ca. 7% with further strong growth from deeper penetration of Fasteners into the Aerospace market.

The company will announce its results for the year ending 30 September 2019 on 18 November 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. U.S. President Donald Trump has issued executive orders to ban Chinese mobile application TikTok as well as WeChat, citing a threat to national security and its economy. China's ByteDance Ltd. owns TikTok, a video-sharing mobile app, while Tencent Holdings Ltd. owns WeChat, a messaging, social media, and electronic payment app.
RELATED NEWS
Follow RTT